BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Radi Medical Systems AB Announces Schedule for TCT 2008 FFR Case Review With Drs. William F. Fearon, Morton J. Kern and Peter Ver Lee Among the Highlights


10/8/2008 9:36:01 PM

WILMINGTON, Massachusetts, October 8 /PRNewswire/ -- The use of fractional flow reserve (FFR) for optimizing patient outcomes is the topic of multiple sessions at this year's Transcatheter Cardiovascular Therapeutics symposium, TCT 2008, which will take place Oct. 12-17 in Washington, D.C.

Radi Medical Systems, the first company to develop systems that calculate FFR with the physiologic assessment of targeted lesions, is sponsoring a breakfast session, "Intervention Under Pressure: Discovering the best way with FFR," at 7 a.m. EDT on Tuesday, Oct. 14, in room 150 B at the Washington Convention Center. During the session, William F. Fearon, M.D., of Stanford University, will discuss FFR measurement in multi vessel disease, Morton J. Kern, M.D., of the University of California, Irvine, will speak about FFR measurement in challenging lesion subsets, and Peter Ver Lee, M.D., of the Eastern Maine Medical Center, will provide an overview of FFR measurement in private practice.

Following the session, data from the study titled "Fractional flow reserve vs. Angiography for Multivessel Evaluation" (FAME) will be presented by Dr. Fearon and Nico Pijls, M.D., Ph.D., in the Main Arena at 11:45 a.m. EDT. FAME is the world's first randomized, prospective, multicenter trial to compare clinical outcomes and the cost-effectiveness of a physiologic-guided percutaneous coronary intervention (PCI) strategy to an angiographic-guided one in patients with multi vessel coronary artery disease

"We are excited to discuss topics pertaining to fractional flow reserve measurement, a few hours before data from the FAME study is presented in the Main Arena," said Jason Rudy, Director of Marketing of Radi Medical Systems Inc. "We anticipate that these will be two engaging sessions that educate about the benefits of FFR use in today's cathlab."

Radi Medical Systems will be exhibiting at booth 1203 and will displaying their most recent PressureWire(R) system and updated FemoStop(R) Gold Femoral Compression System.

About Fractional Flow Reserve, FFR

Fractional Flow Reserve (FFR) is an index for functional severity of coronary stenosis, measured by PressureWire(R). FFR is 100% specific in identifying which lesion or lesions are responsible for a patient's ischemia and it is used by the interventional cardiologist to direct coronary interventions and assess results for improved treatment outcomes.

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 380 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, Mass. For more information, visit http://www.radi.se.

CONTACT: Media Contacts: Ian Stone or David Schull, Russo Partners,
+1-619-814-3510 office, +1-858-717-4480 mobile,
ian.stone@russopartnersllc.com, david.schull@russopartnersllc.com; Jason
Rudy, Radi Medical Systems Inc., +1-877-337-7234 x828, jason.rudy@radi.se



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES